LISA KING: Open Payments
NPI 1043288806 · RICHLAND, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 11 payments from 10 companies in 2025. Trend: 2023 $487 · 2024 $364 · 2025 $206
Food & beverage: $206
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Dexcom, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Boston Scientific Corporation | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
Products named: CAPLYTA, Ozempic, Dexcom G6 Transmitter, FANAPT, Axonics, PREVNAR 20, AUSTEDO XR, VRAYLAR.
Industry payments across MO — which companies pay providers there.
